Knoll Pharmaceutical Co.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Knoll Pharmaceutical Co.
AbbVie’s Downward Humira Guidance Worries Analysts
Decreasing Humira’s ex-US sales guidance for the second time in three months caught significant attention, as AbbVie now expects 30% revenue erosion for its top-seller outside its home market.
External R&D Is Up, But Which Companies Are Reaping The Most Benefit?
Amgen, Novartis and Lilly are projected to increase sales from externally sourced assets in the coming years, according to a Datamonitor Healthcare analysis, while other big pharma – including frequent acquirer Pfizer and smaller-deal-oriented Bristol – are expected to see that ratio decline compared to sales of internally developed drugs.
Turkey Company Roundup: Baxter Rejigs JV, Sanofi Mulls Insulin Plant
Following its spin-off from Baxter, Baxalta has formed a new partnership with a leading Turkish firm, while Sanofi Turkey is considering the local manufacture of an insulin product. Elsewhere, senior management changes have taken place at GSK and Bayer.
Eric Colman, FDA’s Lead Obesity Drug Reviewer, Dies At Age 53
As a reviewer, team leader and deputy director in the Division of Metabolism and Endocrinology Products, Colman spearheaded the agency’s policy development on weight-management products.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.